ONCIMMUNE HOLDINGS PLC Logo

ONCIMMUNE HOLDINGS PLC

Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.

ONC | IL

Overview

Corporate Details

ISIN(s):
GB00BYQ94H38
LEI:
213800HCYIWT6YPI1I02
Country:
United Kingdom
Address:
CLINICAL SCIENCES BUILDING CITY HOSPITAL, NG5 1PB NOTTINGHAM
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Oncimmune Holdings PLC is a precision medicine company specializing in antibody biomarker discovery to support the development of targeted therapies. Its core offering is the proprietary ImmunoINSIGHTS™ platform, an analytical engine that profiles autoantibodies from minimal biological samples. Leveraging one of the world's largest antigen libraries (over 9000 antigens), high-throughput automated workflows, and advanced bioinformatics, the platform provides insights for pharmaceutical and biotechnology partners. The company's services focus on biomarker discovery and targeted panels for applications in immuno-oncology, autoimmune diseases, and infectious diseases, aiming to enable more effective and safer treatments.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-26 13:45
Legal Proceedings Report
Appointment of Administrators & Nomad Resignation
English 9.0 KB
2025-03-19 08:00
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-03-17 08:00
Delisting Announcement
Intention to Appoint Administrators and Suspension
English 11.4 KB
2025-03-14 08:00
Share Issue/Capital Change
Block Listing Return
English 12.3 KB
2025-03-10 14:39
Post-Annual General Meeting Information
Result of GM
English 14.5 KB
2025-02-27 17:18
Post-Annual General Meeting Information
Result of AGM
English 13.5 KB
2025-02-24 08:00
Business and Financial Review
Strategic update
English 11.1 KB
2025-02-18 08:00
Major Shareholding Notification
Holding(s) in Company
English 23.3 KB
2025-02-12 08:01
Share Issue/Capital Change
Block Listing Return
English 12.3 KB
2025-02-12 08:00
Pre-Annual General Meeting Information
Posting of Notice of General Meeting
English 8.1 KB
2025-02-10 08:00
Earnings Release
Final Results
English 154.5 KB
2025-02-04 11:38
Major Shareholding Notification
Holding(s) in Company
English 23.2 KB
2025-02-03 08:00
Pre-Annual General Meeting Information
Notice of Annual General Meeting
English 8.2 KB
2025-01-31 08:00
Earnings Release
Trading Update
English 13.6 KB
2024-12-10 16:36
Major Shareholding Notification
Holding(s) in Company
English 23.2 KB

Automate Your Workflow. Get a real-time feed of all ONCIMMUNE HOLDINGS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ONCIMMUNE HOLDINGS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Medivir Logo
Clinical-stage pharma firm developing tumor-directed therapies for high-need cancer patients.
Sweden MVIR
Sweden MBOLIC
Milton Essex Spolka Akcyjna Logo
Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.
Poland MTN
Molecular Partners AG Logo
Pioneering DARPin protein drugs for complex diseases in oncology and virology.
Switzerland MOLN
MorphoSys AG Logo
Biopharma company creating antibody therapies for oncology, with a focus on blood cancers.
Germany MOR
Mycodern Spolka Akcyjna Logo Poland MCD
N4 PHARMA PLC Logo
Developing a nanoparticle delivery system for advanced gene and vaccine therapies.
United Kingdom N4P
NextGen Biomed Ltd. Logo
R&D of biotech medical devices for diabetes care and topical skin treatments.
Israel NXGN
Nicox S.A. Logo
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France COX
OncoZenge AB Logo
Developing a non-opioid lozenge for oral pain relief in cancer patients.
Sweden ONCOZ

Talk to a Data Expert

Have a question? We'll get back to you promptly.